- Home
- SWIN vs BRNS Comparison
SWIN vs BRNS Comparison
Compare SWIN & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- BRNS
- Stock Information
- Founded
- SWIN 2017
- BRNS 2016
- Country
- SWIN Hong Kong
- BRNS United Kingdom
- Employees
- SWIN N/A
- BRNS N/A
- Industry
- SWIN
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- BRNS Health Care
- Exchange
- SWIN Nasdaq
- BRNS Nasdaq
- Market Cap
- SWIN 32.1M
- BRNS 36.0M
- IPO Year
- SWIN 2023
- BRNS 2021
- Fundamental
- Price
- SWIN $3.90
- BRNS $1.00
- Analyst Decision
- SWIN
- BRNS Strong Buy
- Analyst Count
- SWIN 0
- BRNS 1
- Target Price
- SWIN N/A
- BRNS $3.00
- AVG Volume (30 Days)
- SWIN 274.8K
- BRNS 11.6K
- Earning Date
- SWIN 08-21-2025
- BRNS 08-07-2025
- Dividend Yield
- SWIN N/A
- BRNS N/A
- EPS Growth
- SWIN N/A
- BRNS N/A
- EPS
- SWIN N/A
- BRNS N/A
- Revenue
- SWIN $3,316,000.00
- BRNS $14,969,000.00
- Revenue This Year
- SWIN $29.79
- BRNS N/A
- Revenue Next Year
- SWIN $54.60
- BRNS N/A
- P/E Ratio
- SWIN N/A
- BRNS N/A
- Revenue Growth
- SWIN N/A
- BRNS 4381.74
- 52 Week Low
- SWIN $1.16
- BRNS $0.64
- 52 Week High
- SWIN $3.92
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- SWIN 83.35
- BRNS 53.30
- Support Level
- SWIN $2.88
- BRNS $0.90
- Resistance Level
- SWIN $3.48
- BRNS $0.94
- Average True Range (ATR)
- SWIN 0.33
- BRNS 0.05
- MACD
- SWIN 0.13
- BRNS 0.00
- Stochastic Oscillator
- SWIN 97.22
- BRNS 96.80
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.